Zobrazeno 1 - 10
of 93
pro vyhledávání: '"Ansgar, Weltermann"'
Autor:
Alexander Nikoloudis, Irene Strassl, Michaela Binder, Olga Stiefel, Dagmar Wipplinger, Robert Milanov, Christoph Aichinger, Emine Kaynak, Sigrid Machherndl-Spandl, Veronika Buxhofer-Ausch, Alexandra Böhm, Andreas Petzer, Ansgar Weltermann, Dominik Wolf, David Nachbaur, Johannes Clausen
Publikováno v:
Transplantology, Vol 4, Iss 1, Pp 22-37 (2023)
Background: Serotherapy with anti-T lymphocyte globulin (ATLG, Grafalon, formerly ATG-Fresenius) is established for the prevention of severe graft-versus-host disease (GVHD) after hematopoietic stem cell transplantation (HSCT). The evidence from pros
Externí odkaz:
https://doaj.org/article/821c39888d64463a8b3ef666b5ff18b5
Autor:
Irene Strassl, Alexander Nikoloudis, Sigrid Machherndl-Spandl, Veronika Buxhofer-Ausch, Michaela Binder, Dagmar Wipplinger, Olga Stiefel, Emine Kaynak, Robert Milanov, Christoph Aichinger, Stefanie Nocker, Thomas Bauer, Stefanie Kreissl, Michael Girschikofsky, Andreas Petzer, Ansgar Weltermann, Johannes Clausen
Publikováno v:
Cancers, Vol 15, Iss 24, p 5738 (2023)
Background: Despite major treatment advances, multiple myeloma remains incurable. The outcome of patients who are refractory to immunomodulatory agents, proteasome inhibitors, and anti-CD38 monoclonal antibodies is poor, and improved treatment strate
Externí odkaz:
https://doaj.org/article/ab854ed8098748d6b5657fc8c73295a6
Autor:
Alexander Nikoloudis, Ines Julia Neumann, Veronika Buxhofer-Ausch, Sigrid Machherndl-Spandl, Michaela Binder, Emine Kaynak, Robert Milanov, Stefanie Nocker, Olga Stiefel, Irene Strassl, Dagmar Wipplinger, Margarete Moyses, Heidrun Kerschner, Petra Apfalter, Michael Girschikofsky, Andreas Petzer, Ansgar Weltermann, Johannes Clausen
Publikováno v:
Vaccines, Vol 11, Iss 10, p 1534 (2023)
(1) Background: mRNA COVID-19 vaccines are effective but show varied efficacy in immunocompromised patients, including allogeneic hematopoietic stem cell transplant (HSCT) recipients. (2) Methods: A retrospective study on 167 HSCT recipients assessed
Externí odkaz:
https://doaj.org/article/8fe579c44ccc4d78963dac1562610171
Autor:
Alexander Nikoloudis, Veronika Buxhofer-Ausch, Christoph Aichinger, Michaela Binder, Petra Hasengruber, Emine Kaynak, Dagmar Wipplinger, Robert Milanov, Irene Strassl, Olga Stiefel, Sigrid Machherndl-Spandl, Andreas Petzer, Ansgar Weltermann, Johannes Clausen
Publikováno v:
Cells, Vol 12, Iss 14, p 1831 (2023)
Background: In allogeneic hematopoietic stem cell transplantation (HSCT), Anti-T-Lymphocyte Globulin (ATLG) may be used for the prevention of severe graft-versus-host disease (GVHD). ATLG targets both the recipient’s lymphocytes and those transferr
Externí odkaz:
https://doaj.org/article/8275ebe284af4ad4abb89ebb00fc9f01
Autor:
Sigrid, Machherndl-Spandl, Thomas, Vockenhuber, Michaela, Binder, Ansgar, Weltermann, Petra, Apfalter, Cornelia, Lass-Flörl, Michael, Girschikofsky
Publikováno v:
Leukemia & Lymphoma. 63:2330-2335
Invasive fungal infections (IFIs) are commonly observed in patients, who are at high risk of severe infections during the neutropenic phase. The aim of this retrospective single-center study was to evaluate the efficacy and safety of voriconazole as
Autor:
Irene Strassl, Armin Windhager, Sigrid Machherndl-Spandl, Veronika Buxhofer-Ausch, Olga Stiefel, Ansgar Weltermann
Publikováno v:
Journal of Cancer Research and Clinical Oncology.
Purpose Polypharmacy is a significant problem in patients with incurable cancer and a method to optimize pharmacotherapy in this patient group is lacking. Therefore, a drug optimization tool was developed and tested in a pilot test. Methods A multidi
Autor:
Klaus Geissler, Eva Jäger, Agnes Barna, Michael Gurbisz, Temeida Graf, Elmir Graf, Thomas Nösslinger, Michael Pfeilstöcker, Heinz Tüchler, Thamer Sliwa, Felix Keil, Christoph Geissler, Sonja Heibl, Josef Thaler, Sigrid Machherndl-Spandl, Otto Zach, Ansgar Weltermann, Peter Bettelheim, Reinhard Stauder, Armin Zebisch, Heinz Sill, Ilse Schwarzinger, Bruno Schneeweiss, Leopold Öhler, Ernst Ulsperger, Rajko Kusec, Ulrich Germing, Wolfgang R. Sperr, Paul Knöbl, Ulrich Jäger, Gregor Hörmann, Peter Valent
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 8, p 3025 (2020)
Although the RAS-pathway has been implicated as an important driver in the pathogenesis of chronic myelomonocytic leukemia (CMML) a comprehensive study including molecular and functional analyses in patients with progression and transformation has no
Externí odkaz:
https://doaj.org/article/30ffd1efa4884aaf8f1fcb42a6bb4542
Autor:
Ernst Ulsperger, Elmir Graf, Reinhard Stauder, Eva Jäger, Klaus Geissler, Heinz Tüchler, Josef Thaler, Ulrich Germing, Peter Valent, Ansgar Weltermann, Christoph Geissler, Sonja Heibl, Renate Marschon, Agnes Barna, Armin Zebisch, Michael Pfeilstöcker, Leopold Öhler, Rajko Kusec, Otto Zach, Bruno Schneeweiss, Michael Gurbisz, Temeida Graf, Peter Bettelheim, Heinz Sill, Sigrid Machherndl-Spandl, Gerald Webersinke, Gregor Hoermann, Thomas Nösslinger
Publikováno v:
European Journal of Haematology
In older patients with chronic myelomonocytic leukaemia (CMML) and limited life expectancy due to age and or comorbidities, it is particularly important to consider the risk of transformation for individualised treatment decisions. There is limited i
Autor:
Rupert Bartsch, Anna Sophie Berghoff, Julia Furtner, Maximilian Marhold, Elisabeth Sophie Bergen, Sophie Roider-Schur, Angelika Martina Starzer, Heidrun Forstner, Beate Rottenmanner, Karin Dieckmann, Zsuzsanna Bago-Horvath, Helmuth Haslacher, Georg Widhalm, Aysegül Ilhan-Mutlu, Christoph Minichsdorfer, Thorsten Fuereder, Thomas Szekeres, Leopold Oehler, Birgit Gruenberger, Christian F. Singer, Ansgar Weltermann, Rainer Puhr, Matthias Preusser
Publikováno v:
Nature medicine. 28(9)
Trastuzumab deruxtecan is an antibody–drug conjugate with high extracranial activity in human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer. We conducted the prospective, open-label, single-arm, phase 2 TUXEDO-1 trial.
Autor:
Michael Fiegl, Wolfgang Hilbe, Hellmut Samonigg, David Fuchs, H. Stöger, Maria Johanna Schandl, Josef Thaler, Heinz Ludwig, Marija Balic, Peter Krippl, Andreas L. Petzer, Beate Mayrbäurl, Reinhard Stauder, Richard Greil, Sylvia Gusel, Brigitte Mlineritsch, Florian Eisner, Wolfgang Stangl, Ansgar Weltermann, Karin Hegenbarth
Publikováno v:
memo - Magazine of European Medical Oncology. 12:290-296
Summary The purpose of this observational study was to determine the prevalence of comorbid conditions in cancer patients with solid tumours selected for specific treatment at 12 divisions of medical oncology in Austria. Data from 1137 patients were